Skip to main content
. Author manuscript; available in PMC: 2017 Aug 22.
Published in final edited form as: J Invest Dermatol. 2016 Nov 1;137(4):819–827. doi: 10.1016/j.jid.2016.10.028

Figure 3. Kaplan-Meier curves of survival among MCC patients whose tumors were MCPyV-positive or -negative.

Figure 3

(a) Patients with virus-negative tumors had significantly decreased progression-free survival (P = 0.0052). (b) Patients with virus-negative tumors had significantly decreased MCC-specific survival (P = 0.015). (c) Patients with virus-negative tumors had a nonsignificant trend for poorer overall survival (P = 0.14). MCC, Merkel cell carcinoma.